-
D.C. prepares for Trump’s return, as a criminal defendant
Police officials said they were discussing security measures ahead of the former president’s court appearance.
-
Jeffrey Clark plotted to reverse Trump’s loss. Now he’s a GOP luminary.
After trying to use the Justice Department to delegitimize the 2020 vote, Clark has become a rising legal star for Republicans.
-
Trump’s election lies and the Republicans who corrected him
A chorus of top Republicans told Trump repeatedly that his claims of widespread voter fraud were false.
-
Trump 2024: Running for President, and to Beat the Rap
Donald J. Trump has long understood the stakes in the election: The courts may decide his cases, but only voters can decide whether to return him to power.
-
Trump Indictment Leaves Alleged Co-Conspirators Facing Tough Choices
The special counsel’s decision not to charge six people said to have played critical roles in the effort to keep Donald Trump in office seemed to give them a chance to cooperate with prosecutors. Some appear to be unwilling.
-
Impact of the Pandemic and the End of the Public Health Emergency on Opioid Use Disorder Treatment
This report was written in partnership with and funded by the Foundation for Opioid Response Efforts. During the COVID-19 pandemic, the federal government and many states offered regulatory flexibilities intended to make it easier for people with opioid use disorder (OUD) to get treatment. Now that the public health emergency (PHE) declaration has come to…
-
California Court Casts Doubt on Copyright Claims Relating to AI Images
Several U.S. courts are addressing lawsuits brought by artists alleging that AI-generated art infringes on copyrights held by the artists for their artwork. In one of those cases, a California federal judge recently indicated that he would dismiss the bulk of the plaintiffs’ complaint, while giving them a chance to re-plead their claims. A written…
-
FDA’s LDT Proposed Rule Heads to the White House
As discussed in our June Insight, earlier this year FDA publicly announced its development of a proposed rule that would expressly define laboratory developed tests (“LDTs”) as medical devices and subject them to the agency’s regulatory authority. Such a rule would be FDA’s first comprehensive attempt to impose its authority over LDTs since its 2014…
-
Take Two: The Lummis-Gillibrand Crypto Assets Bill 2.0
On July 12, Senator Kirsten Gillibrand, a Democratic senator from New York who sits on the Senate Banking Committee, and Senator Cynthia Lummis, a Republican senator from Wyoming who sits on the Agriculture Committee, joined forces again to propose a comprehensive bill that seeks to organize and operationalize the Federal Government’s response to crypto activities…
-
Are There Any Risks to Using AI to Enhance Diversity in the Workplace?
Q: Are there any risks to using AI to enhance diversity in the workplace?…By: Troutman Pepper
